1 / 4

Top10 Companies in Cancer-Tumor Profiling Market’

Cancer/Tumor Profiling Market by Biomarker Type (Genetic, Protein) Technology (NGS, PCR, ISH, IHC) Cancer Type (Breast, Lung, Colorectal, Prostate, Leukemia) Application (Clinical, Research) End User (Pharma, Academic, CRO) - Global Forecast to 2030

ankita84
Download Presentation

Top10 Companies in Cancer-Tumor Profiling Market’

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. "Top 10 Companies in Cancer/Tumor Profiling Market’’

  2. Cancer/Tumor Profiling Market 2023-2030 The Cancer/Tumor Profiling Market is poised to witness substantial growth, projecting a robust Compound Annual Growth Rate (CAGR) of 20.9% and an estimated market value exceeding $22.3 billion by 2030, according to a recent report by Meticulous Research®. The evolution of precision oncology, marked by the alignment of the right treatment with the right patient at the right time, has significantly propelled cancer care, contributing to a 27% decline in cancer mortality rates from 2001 to 2020. Precision Oncology Revolution: The success in reducing mortality rates is primarily attributed to the adoption of targeted therapies, addressing specific gene mutations driving cancer. This marks a departure from the traditional one-size-fits-all approach of chemotherapy. Notably, targeted treatments for advanced lung cancer have seen a substantial increase, with over 15 FDA approvals since 2020. Adoption of Cancer/Tumor Profiling: Oncologists and pathologists are increasingly turning to cancer/tumor profiling to enhance their capabilities in identifying actionable biomarkers. This enables precise matching of patients for clinical trials and precision therapies, marking a paradigm shift in cancer treatment. Market Drivers: The growth of the cancer/tumor profiling market is propelled by factors such as the increasing prevalence of cancer, advancements in multi-omics tumor profiling and cancer research, rising R&D investments by pharmaceutical and biotechnology companies for biomarker development, government initiatives aimed at reducing cancer mortality, and the utilization of biomarkers in tumor profiling. Top 10 Companies in the Cancer/Tumor Profiling Market: Here are the leading companies driving innovation in the Cancer/Tumor Profiling Market: https://meticulousblog.org/top-10-companies-in-cancer-tumor-profiling- market/ 1.Illumina, Inc. (U.S.) •Core Illumina segment offers cancer/tumor profiling solutions. •Global distribution in North America, Europe, Latin America, Asia- Pacific, and the Middle East & Africa. 2.Thermo Fisher Scientific Inc. (U.S.) •Operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. •Geographical presence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. 3.QIAGEN N.V. (Netherlands) •Provides sample and assay technologies for molecular diagnostics and research. Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

  3. Cancer/Tumor Profiling Market 2023-2030 •Global market presence in more than 130 countries. 4.F. Hoffmann-La Roche Ltd (Switzerland) •Engaged in Pharmaceuticals and Diagnostics divisions. •Global presence in the U.S., Germany, Switzerland, Japan, China, India, and more. 5.Agilent Technologies, Inc. (U.S.) •Offers application-focused solutions to life sciences, diagnostics, and applied chemical markets. •Geographical presence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. 6.NanoString Technologies, Inc. (U.S.) •Focuses on proteomics and genomics solutions. •Global presence in North America, Europe, and Asia-Pacific. 7.HTG Molecular Diagnostics, Inc. (U.S.) •Specializes in advanced drug discovery and transcriptome-wide profiling. •Sales presence in Austria, Belgium, France, Germany, Luxembourg, the Netherlands, the U.K., and Switzerland. 8.Agendia Inc. (U.S.) •Molecular diagnostics company focused on breast cancer. •Global delivery through Agendia N.V. (Netherlands). 9.Personalis, Inc. (U.S.) •Develops comprehensive genomic tests with actionable insights. •Serves diagnostics companies, pharmaceutical companies, universities, and more. 10.Exact Sciences Corporation (U.S.) •Provides advanced cancer diagnostics solutions. •Operates throughout the U.S., Canada, Japan, and eight European countries. Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5630 Upcoming Industry Insights: For in-depth analysis, including recent financial performance, key products, company strategies, and partnerships and acquisitions, Meticulous Research®'s latest report on the Cancer/Tumor Profiling Market – Global Opportunity Analysis and Industry Forecast (2023-2030) provides comprehensive coverage. For further information, please contact: Contact Us: Meticulous Research® Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

  4. Cancer/Tumor Profiling Market 2023-2030 Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous- research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com

More Related